These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22314650)

  • 41. Interstitial cystitis/bladder pain syndrome: an update.
    Dasgupta J; Tincello DG
    Maturitas; 2009 Dec; 64(4):212-7. PubMed ID: 19837525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Jiang YH; Jhang JF; Hsu YH; Kuo HC
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bladder necrosis following hydrodistention in patients with interstitial cystitis.
    Zabihi N; Allee T; Maher MG; Mourtzinos A; Raz S; Payne CK; Rodríguez LV
    J Urol; 2007 Jan; 177(1):149-52; discussion 152. PubMed ID: 17162025
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short interval between symptom onset and medical care as an indication of rapid onset of interstitial cystitis/painful bladder syndrome.
    Greenberg P; Tracy JK; Meyer WA; Yates T; Diggs C; Warren JW
    BJU Int; 2007 Sep; 100(3):599-602; discussion 602. PubMed ID: 17542989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bladder outlet obstruction in painful bladder syndrome/interstitial cystitis.
    Cameron AP; Gajewski JB
    Neurourol Urodyn; 2009; 28(8):944-8. PubMed ID: 19301413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of bladder blood flow in patients with and without interstitial cystitis.
    Pontari MA; Hanno PM; Ruggieri MR
    J Urol; 1999 Aug; 162(2):330-4. PubMed ID: 10411032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of the neodymium: YAG laser for interstitial cystitis: a prospective study.
    Rofeim O; Hom D; Freid RM; Moldwin RM
    J Urol; 2001 Jul; 166(1):134-6. PubMed ID: 11435840
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Goal achievement provides new insights into interstitial cystitis/painful bladder syndrome symptoms and outcomes.
    Payne C; Allee T
    Neurourol Urodyn; 2009; 28(1):13-7. PubMed ID: 19089894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multifactorial causes of irritating bladder symptoms in patients with Sjögren's syndrome.
    Lee KL; Dong CS; Chen MY; Ho CH; Tai HC; Hung SF; Yu HJ
    Neurourol Urodyn; 2011 Jan; 30(1):97-101. PubMed ID: 20928912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis.
    Zhang CO; Li ZL; Kong CZ
    BMC Urol; 2005 Apr; 5():7. PubMed ID: 15862132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Posterior tibial nerve stimulation twice a week in patients with interstitial cystitis.
    Zhao J; Bai J; Zhou Y; Qi G; Du L
    Urology; 2008 Jun; 71(6):1080-4. PubMed ID: 18372023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonbladder related symptoms in patients with interstitial cystitis.
    Erickson DR; Morgan KC; Ordille S; Keay SK; Xie SX
    J Urol; 2001 Aug; 166(2):557-61; discussion 561-2. PubMed ID: 11458068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis?
    Erickson DR; Tomaszewski JE; Kunselman AR; Bentley CM; Peters KM; Rovner ES; Demers LM; Wheeler MA; Keay SK
    J Urol; 2005 Jan; 173(1):93-7. PubMed ID: 15592040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modified Thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction.
    Oyama IA; Rejba A; Lukban JC; Fletcher E; Kellogg-Spadt S; Holzberg AS; Whitmore KE
    Urology; 2004 Nov; 64(5):862-5. PubMed ID: 15533464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interstitial cystitis and painful bladder syndrome.
    Payne CK; Joyce GF; Wise M; Clemens JQ;
    J Urol; 2007 Jun; 177(6):2042-9. PubMed ID: 17509284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis.
    Peng CH; Kuo HC
    Urol Int; 2007; 78(1):78-81. PubMed ID: 17192738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Over expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in patients with interstitial cystitis and bladder carcinoma.
    Ueda T; Tamaki M; Ogawa O; Yoshimura N
    J Urol; 2002 Jan; 167(1):347-51. PubMed ID: 11743354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
    Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study.
    Comiter CV
    J Urol; 2003 Apr; 169(4):1369-73. PubMed ID: 12629364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Self-perception of symptoms, medical help seeking, and self-help strategies of women with interstitial cystitis/painful bladder syndrome.
    Chen HC; Liu CY; Liao CH; Tsao LI
    Low Urin Tract Symptoms; 2020 Sep; 12(3):183-189. PubMed ID: 31970901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.